CompletedPhase 3NCT02205541
Eculizumab in Shiga-toxin Related Hemolytic and Uremic Syndrome Pediatric Patients - ECULISHU
Studying Hemolytic uremic syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital, Toulouse
- Principal Investigator
- Arnaud Garnier, MDUniversity Hospital, Toulouse
- Intervention
- Eculizumab(drug)
- Enrollment
- 100 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2015 – 2018
Study locations (18)
- University Hospital, Amiens, France
- University Hospital, Angers, France
- University Hospital, Besançon, France
- Pellegrin Hospital, Bordeaux, France
- Morvan Hospital, Brest, France
- University Hospital, Grenoble, France
- Jeanne de Flandre Hospital, Lille, France
- Mother and Child Hospital, Limoges, France
- Women, Mother and Child Hospital, Lyon, France
- La Timone Hospital, Marseille, France
- University Hospital, Montpellier, France
- Mother and Child Hospital, Nantes, France
- Robert Debré Hospital, Paris, France
- Trousseau Hospital, Paris, France
- Necker Hospital, Paris, France
- +3 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02205541 on ClinicalTrials.govOther trials for Hemolytic uremic syndrome
Additional recruiting or active studies for the same condition.